Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

My Primary School Visit for Science Week

On 2 March 2022, Dr Katherine Brimblecombe visited two primary school classes (ages 8-11) as part of their “Science week”. Read her interview to learn more about public engagement with school children in the local Oxford community.

OPDC researchers welcome Parkinson’s UK and the Oxford Branch committee

Cragg Group News OPDC News Wade-Martins Group News

Researchers from the Oxford Parkinson’s Disease Centre (OPDC) recently hosted Caroline Rassell, Parkinson’s UK Chief Executive; David Dexter, Associate Research Director; Trustee Board members, Gary Shaughnessy (Chair) and Sally Bromley; together with members of the Parkinson’s UK Oxford Branch committee, for a visit to showcase the research being carried out in Oxford.

Parkinson's protein test could lead to earlier and better diagnosis

OPDC News

OPDC's Associate Professor Laura Parkkinen, and her team has conducted a study published in Brain, funded by the charity Parkinson’s UK and Weston Brain Institute.

Mapping uncharted networks in the progression of Parkinson’s

Cragg Group News OPDC News Research Wade-Martins Group News

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.

New laboratory facilities for OPDC Researchers

OPDC News Wade-Martins Group News

Researchers from the OPDC and the Wade-Martins Group recently moved to brand new laboratory facilities at the Kavli Institute for NanoScience Discovery.

The only way is UPP!

OPDC News

The OPDC is delighted to announce that Parkinson’s UK have agreed to fund a further four and a half years of ODPC Discovery Cohort follow-up from August 2021.

New laboratory space for OPDC Researchers

OPDC News Wade-Martins Group News

A major building in the centre of Oxford has been constructed to create a new research centre bringing together cellular neuroscience and physical sciences.

Dopamine neurons need a 'REST' in Parkinson’s Disease

OPDC News Wade-Martins Group News

A study led by University of Oxford researchers, Dr Brent Ryan and Dr Nora Bengoa-Vergniory has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson’s Disease.

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease

OPDC News Wade-Martins Group News

A study led by the Oxford Parkinson’s Disease Centre’s (OPDC) Dr Nora Bengoa-Vergniory has shown that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer’s disease before current detection methods.

Dayne Beccano-Kelly awarded UKRI Future Leaders Fellowship

OPDC News

New Future Leaders Fellow Dr Beccano-Kelly will lead research into synaptic health over time in neurodegeneration. Watch our video interview with Dayne to find out more about his career to date, successful application and future plans.

Sites of early dysfunction in Parkinson's identified

OPDC News

A new collaborative study from the Oxford Parkinson’s Disease Centre led by Prof Stephanie Cragg and Dr Bradley Roberts has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.

Tiny brain “tweezers” could hold the key to treat Parkinson’s

OPDC News

A collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.

Dayne Beccano-Kelly appointed World Parkinson Coalition Science Ambassador

OPDC News

The World Parkinson Coalition has brought in eight new Science Ambassadors to increase outreach to researchers ahead of their next major Congress.

Genetic study points to cells responsible for Parkinson’s

OPDC News

New results from a collaborative Oxford Parkinson’s Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments.

Natalie Connor-Robson widens access to STEM skills with In2scienceUK

OPDC News

OPDC Career Development Fellow Natalie Connor-Robson was first generation in her family to go to university and is now delighted to be sharing STEM career advice with students taking part in the In2scienceUK programme.

Oxford Parkinson's Disease Centre pays tribute to one of its loyal fundraisers

OPDC News

Researchers from the Oxford Parkinson’s Disease Centre (OPDC) have been paying tribute to Bobbie Coelho, one of the OPDC’s long term fundraisers who has decided to take a step back from active fundraising activities.

Black In Neuro Week: Dayne Beccano-Kelly on race, academia and research

OPDC News

OPDC Researcher Dr Dayne Beccano-Kelly shares his experience of being a black professional in academia & the wider story of race in research.

OPDC Researchers hit target for Parkinson's UK with 2.6 Challenge

OPDC News

Wade-Martins Lab members took part in the 2.6 challenge to raise vital funds for Parkinson's UK. Challenges included running for 2.6 miles, baking 26 cookies, 260 sit ups and 2600 steps.

Load More